Project Grant R01DK141465
Award Date
9/20/24
Completion Date
5/31/29
Dollars Obligated
$1.5M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $515,244 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the role of brain-derived CCN3 in bone and marrow fat metabolism. The proposed 5-year project aims to determine how circulating levels of CCN3 affect bone formation and the interplay between...
This federal Project Grant award of $253,500.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to develop state-of-the-art approaches to selectively target and degrade a mutant variant of the KLF1 transcription factor, which can lead to congenital dyserythropoietic anemia (CDA) when mutated. The research, summarized in two main aims, will...
This $112,500 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at the Pennington Biomedical Research Center to investigate the mechanisms by which glucocorticoid medications induce insulin resistance and metabolic dysfunction in skeletal muscle. The research will utilize genetic mouse models to understand how limiting...
This Project Grant award of $520,649 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 "Diabetes, Digestive, and Kidney Diseases Extramural Research" will fund research at the Albert Einstein College of Medicine to dissect the differences between hematopoietic stem cells (HSCs) and HSC-independent progenitor cells during embryonic development. The research aims to identify the programs underlying the formation and functions of...
This Project Grant award of $159,512 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to generate a comprehensive single-cell transcriptomic and epigenomic map of human bone marrow cells. The goal is to unravel the complex cellular signaling networks in bone marrow, which is critical for understanding and developing treatments for a wide range of diseases including blood, immune,...
This $553,545 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program supports research aimed at understanding the mechanisms that regulate allelic expression of the Gsα subunit of the stimulatory G protein, and how this impacts hormone signaling and the development of diseases like pseudohypoparathyroidism. The principal investigator and awardee, The...
This Project Grant award, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the role of the protein FGF21 in Duchenne muscular dystrophy (DMD) and its impact on bone health. The $1,727,423 award, with a project period from Aug 2024 to Jun 2029, will support research to identify the cellular sources and molecular mechanisms driving elevated FGF21...
This federal Project Grant award in the amount of $375,100.00, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the cellular mechanisms of age-associated cortical bone remodeling. The two-year deliverables of the proposed study are: 1) identification of myeloid progenitors that aid in maintenance of cortical bone with age, and 2)...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a $1,123,357 research program to investigate the specialized microenvironments within bone marrow that regulate blood cell production. The 7-year project, awarded on January 1, 2025, will focus on three key areas: 1) defining the function of specialized bone marrow microenvironments that serve as niches for different...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to understand the role of the N-terminus of the GATA1 transcription factor in regulating erythropoiesis. The $475,020 award to St. Jude Children's Research Hospital aims to: 1) identify the cofactors recruited by the GATA1 N-terminus to regulate red blood cell development, and 2)...